CROCONAZOLE

CAS No. 77175-51-0

CROCONAZOLE( —— )

Catalog No. M28947 CAS No. 77175-51-0

Croconazole exhibited dose-dependent inhibitory activity on the 5-lipoxygenase (5-LOX) of neutrophils. Croconazole is an antimycotic agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 88 Get Quote
10MG 132 Get Quote
25MG 215 Get Quote
50MG 317 Get Quote
100MG 471 Get Quote
500MG 1053 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CROCONAZOLE
  • Note
    Research use only, not for human use.
  • Brief Description
    Croconazole exhibited dose-dependent inhibitory activity on the 5-lipoxygenase (5-LOX) of neutrophils. Croconazole is an antimycotic agent.
  • Description
    Croconazole exhibited dose-dependent inhibitory activity on the 5-lipoxygenase (5-LOX) of neutrophils. Croconazole is an antimycotic agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Lipoxygenase
  • Recptor
    Necroptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    77175-51-0
  • Formula Weight
    310.78
  • Molecular Formula
    C18H15ClN2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ClC1=CC=CC(COC2=CC=CC=C2C(=C)N2C=CN=C2)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cao M , et al. Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention. Pharmacol Res. 2015 Oct;100:135-47.
molnova catalog
related products
  • NNK

    NNK is a procarcinogen and a major tobacco-specific toxicant. It inhibits the expression of lysyl oxidase which is a tumor suppressor.

  • L 651896

    L 651896 is a novel leukotriene biosynthesis and 5-lipoxygenase inhibitor for the study of respiratory and cardiovascular diseases.

  • PXS-6302 hydrochlori...

    PXS-6302 hydrochloride is a potent irreversible lysine oxidase (LOX) inhibitor, inhibiting Bovine LOX, rh LOXL1, rh LOXL2, rh LOXL3, and rh LOXL4 with IC50 of 3.7 μM, 3.4 μM, 0.4 μM, 1.5 μM, and 0.3 μM, respectively.